A new, clinically-based algorithm for the diagnosis of HIV in African tuberculosis patients: Cross-sectional analysis from Mzuzu, Malawi

International Journal of STD and AIDS

Volumn 10, Issue 4, 1999, Pages 231-236

  Kelly, Paul M ^a,b   Cumming, Robert G ^c   Kaldor, John M ^c   Irwig, Les M ^c  

^a St John's Hospital   (Malawi)

^b ROYAL DARWIN HOSPITAL   (Australia)

^c NONE

Author keywords

Africa; Clinical algorithms; Epidemiology; HIV; ROC curves; Tuberculosis

Indexed keywords

ADOLESCENT; ADULT; AFRICA; AGED; ALGORITHM; ARTICLE; CLINICAL FEATURE; DEMOGRAPHY; DISEASE ASSOCIATION; FEMALE; GEOGRAPHIC DISTRIBUTION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LYMPHADENOPATHY; MAJOR CLINICAL STUDY; MALAWI; MALE; PRIORITY JOURNAL; RASH; RECEIVER OPERATING CHARACTERISTIC; SEXUALLY TRANSMITTED DISEASE; THRUSH; TUBERCULOSIS; URBAN AREA;

ADOLESCENT; ADULT; AFRICAN AMERICANS; AFRICAN CONTINENTAL ANCESTRY GROUP; ALGORITHMS; CROSS-SECTIONAL STUDIES; FEMALE; HIV INFECTIONS; HUMANS; MALAWI; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PREVALENCE; ROC CURVE; SENSITIVITY AND SPECIFICITY; TUBERCULOSIS, PULMONARY;

EID: 0032898413     PISSN: 09564624     EISSN: None     Source Type: Journal    
DOI: 10.1258/0956462991913998     Document Type: Article

References (35)

1. 1 Raviglione MC, Snider DE Jr, Kochi A. Global epidemiology of tuberculosis. Morbidity and mortality of a worldwide epidemic. JAMA 1995;273:220-6
2. 2 De Cock KM, Selik RM, Soro B, Gayle H, Colebunders RL. For debate. AIDS surveillance in Africa: a reappraisal of case definitions. BMJ 1991;303:1185-8
3. 3 Colebunders RL, Braun MM, Nzila N, Dikilu K, Muepu K, Ryder R. Evaluation of the World Health Organization clinical case definition of AIDS among tuberculosis patients in Kinshasa, Zaire. J Infect Dis 1989;160:902-3
4. 4 Lucas SB, Hounnou A, Peacock C, et al. The mortality and pathology of HIV infection in a west African city. AIDS 1993;7:1569-79
5. 5 Nunn P, Brindle R, Carpenter L, et al. Cohort study of human immunodeficiency virus infection in patients with tuberculosis in Nairobi, Kenya, Analysis of early (6-month) mortality. Am Rev Respir Dis 1992;146:849-54
6. 6 Elliott AM, Halwiindi B, Hayes RJ. The impact of human immunodeficiency virus on mortality of patients treated for tuberculosis in a cohort study in Zambia. Trans R Soc Trop Med Hyg 1995;89:78-82
7. 7 Perriens JH, St Louis ME, Mukadi YB, et al. Pulmonary tuberculosis in HIV-infected patients in Zaire. A controlled trial of treatment for either 6 or 12 months. N Engl J Med 1995;332:779-84
8. 8 Ackah AN, Coulibaly D, Digbeu H, et al. Response to treatment, mortality, and CD4 lymphocyte counts in HIV-infected persons with tuberculosis in Abidjan, Côte d'Ivoire. Lancet 1995;345:607-10
9. 9 World Health Organization. WHO case definitions for AIDS surveillance in adults and adolescents. Weekly Epidemiol Rec 1994;69:273-80
10. 10 Gilks CF. What use is a clinical case definition for AIDS in Africa? BMJ 1991;303:1189-90
11. 11 Colebunders R, Mann JM, Francis H, et al. Evaluation of a clinical case-definition of acquired immunodeficiency syndrome in Africa. Lancet 1987;1:492-4
12. 12 Colebunders RL, Latif AS. Natural history and presentation of HIV-1 infection in adults. AIDS 1991;5:S103-S112
13. 13 Elliott AM, Luo N, Tembo G, et al. Impact of HIV on tuberculosis in Zambia: a cross sectional study. BMJ 1990;301:412-15
14. 14 Gilks CF, Brindle RJ, Otieno LS, et al. Extrapulmonary and disseminated tuberculosis in HIV-1-seropositive patients presenting to the acute medical services in Nairobi. AIDS 1990;4:981-5
15. 15 De Cock KM, Soro B, Coulibaly IM, Lucas SB. Tuberculosis and HIV infection in sub-Saharan Africa. JAMA 1992;268: 1581-7
16. 16 Batungwanayo J, Taelman H, Dhote R, Bogaerts J, Allen S, Van de Perre P. Pulmonary tuberculosis in Kigali, Rwanda. Impact of human immunodeficiency virus infection on clinical and radiographic presentation. Am Rev Respir Dis 1992;146:53-6
17. 17 Nunn P, Gicheha C, Hayes R, et al. Cross-sectional survey of HIV infection among patients with tuberculosis in Nairobi, Kenya. Tuber Lung Dis 1992;73:45-51
18. 18 Mukadi Y, Perriens JH, St Louis ME, et al. Spectrum of immunodeficiency in HIV-1 infected patients with pulmonary tuberculosis in Zaire. Lancet 1993;342:143-6
19. 19 Naucler A, Winqvist N, Dias F, et al. Pulmonary tuberculosis in Guinea-Bissau: clinical and bacteriological findings, human immunodeficiency virus status and short term survival of hospitalized patients. Tuber Lung Dis 1996;77:226-32
20. 20 International Union Against Tuberculosis and Lung Disease. Tuberculosis Guide for High Prevalence Countries, 2nd edn. Paris: IUATLD, 1991
21. 21 Behets F, Disasi A, Ryder RW, et al. Comparison of five commercial enzyme-linked immunosorbent assays and Western immunoblotting for human immunodeficiency virus antibody detection in serum samples from Central Africa. J Clin Microbiol 1991;29:2280-4
22. 22 Global Programme on AIDS. Recommendations for the selection and use of HIV antibody tests. Weekly Epidemiol Rec 1992;67:145-9
23. 23 Herman AA, Irwig LM, Groeneveld HT. Evaluating obstetric risk scores by receiver operating characteristic curves. Am J Epidemiol 1988;127:831-42
24. 24 Metz CE, Wang PL, Kronman HB. A new approach for testing the significance of differences between ROC curves measured from correlated data. In: Deconinck F, ed. Information Processing in Medical Imaging. The Hague: Martinus Nijhoff, 1984:432-45
25. 25 Kelly P, Burnham G, Radford C. HIV seropositivity and tuberculosis in a rural Malawi hospital. Trans R Soc Trop Med Hyg 1990;84:725-7
26. 26 Migliori GB, Borghesi A, Adriko C, et al. Tuberculosis and HIV infection association in a rural district of Northern Uganda: epidemiological and clinical considerations. Tuber Lung Dis 1992;73:285-90
27. 27 Elliott AM, Halwiindi B, Hayes RJ, et al. The impact of human immunodeficiency virus on presentation and diagnosis of tuberculosis in a cohort study in Zambia. J Trop Med Hyg 1993;96:1-11
28. 28 Harries AD, Maher D, Mvula B, Nyangulu D. An audit of HIV testing and HIV serostatus in tuberculosis patients, Blantyre, Malawi. Tuber Lung Dis 1995;76:413-17
29. 29 Mlika-Cabanne N, Brauner M, Kamanfu G, et al. Radiographic abnormalities in tuberculosis and risk of coexisting human immunodeficiency virus infection. Methods and preliminary results from Bujumbura, Burundi. Am J Respir Crit Care Med 1995;152:794-9
30. 30 Van den Broek J, Mugomela A, O'Brien R. Treatment outcome of HIV+ and HIV-tuberculosis patients in Mwanza, Tanzania. Tuber Lung Dis 1995;76:131
31. 31 Mlika-Cabanna N, Brauner M, Mugusi F, et al. Radiographic abnormalities in tuberculosis and risk of coexisting human immunodeficiency virus infection. Results from Dar-es-Salaam, Tanzania, and scoring system. Am J Respir Crit Care Med 1995;152:786-93
32. 32 Wilkinson D, Moore DA. HIV-related tuberculosis in South Africa - clinical features and outcome. S African Med J 1996;86:64-7
33. 33 Nunn P, Kibuga D, Gathua S, et al. Cutaneous hypersensitivity reactions due to thiacetazone in HIV-1 seropositive patients treated for tuberculosis. Lancet 1991;337:627-30
34. 34 Kaplan JE, Hu DJ, Holmes KK, Jaffe HW, Masur H, De Cock KM. Preventing opportunistic infections in human immunodeficiency virus-infected persons: implications for the developing world. Am J Trop Med Hyg 1996;55:1-11
35. 35 World Health Organization. Acquired immunodeficiency syndrome (AIDS). WHO/CDC case definition for AIDS. Weekly Epidemiol Rec 1986;61:69-73